Tru Independence Asset Management 2, LLC Astrazeneca PLC Transaction History

Tru Independence Asset Management 2, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	BUY	$53.02 - $135.75 $515,990 - $1.32 Million	9,732 Added 248.33%	13,651 $749,000
Q2 2022 Aug 02, 2022	SELL	$59.26 - $71.14 $39,467 - $47,379	-666 Reduced 14.53%	3,919 $259,000
Q1 2022 Apr 27, 2022	BUY	$55.72 - $67.12 $2,953 - $3,557	53 Added 1.17%	4,585 $304,000
Q4 2021 Jan 20, 2022	SELL	$54.02 - $63.83 $46,781 - $55,276	-866 Reduced 16.04%	4,532 $264,000
Q3 2021 Nov 05, 2021	SELL	$55.56 - $60.79 $54,671 - $59,817	-984 Reduced 15.42%	5,398 $324,000
Q1 2021 May 19, 2021	SELL	$47.16 - $54.44 $34,285 - $39,577	-727 Reduced 10.23%	6,382 $317,000
Q4 2020 Mar 09, 2021	BUY	$48.52 - $58.02 $344,928 - $412,464	7,109 New	7,109 $355,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Tru Independence Asset Management 2, LLC, based on Form 13F filings with the SEC.

Stay updated on Tru Independence Asset Management 2, LLC with notifications on news.